Skip to main content
Caplight Logo









Triangle Biotechnology, Inc.

Triangle Biotechnology, Inc.

Private
Chapel Hill, North CarolinaHealthcare & Life Scienceshttps://trianglebio.com/

Last Round

Debt

Aug 2, 2022

Total Funding Raised

$2.57M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Triangle Biotechnology, Inc. is a biotechnology company that develops acoustic processing technologies and sonication reagents to improve the efficiency of biological sample preparation for next-generation sequencing and epigenetic assays.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

sample preparationsonicationDNA shearingnext-generation sequencingNGSchromatin shearingcell lysislab automationbiotech reagentsepigenetic assaysmolecular biologyhigh-throughput screeningbenchtop lab equipmentChIP-Seqproteomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Triangle Biotechnology, Inc. Comparables

Compare Triangle Biotechnology, Inc. with similar companies based on industry and business-model similarity.

Triangle Biotechnology, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hologic, Inc.
76%
PerkinElmer
74%
Active Motif
71%

Triangle Biotechnology, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtAug 2, 2022
GrantFeb 2, 2021
GrantSep 8, 2020
GrantApr 9, 2019
AcceleratorJan 1, 2018

Key People

Founding team and executive leadership

Sunny Kasoji

CEO

Executive Team

Triangle Biotechnology, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 4280% MoM, from 40 to 1.8K.

  • Jun 19, 2026

    Monthly visitors increased 333% from 49 to 212.

Triangle Biotechnology, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Triangle Biotechnology, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Triangle Biotechnology, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersChapel Hill, North Carolina
Employee Range4
Year Founded2018
Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?